Relapsing remitting encephalomyelitis with glutamic acid decarboxylase antibodies following autologous haematopoietic stem cell transplantation-coincidence or consequence?

Neurol Sci. 2024 Feb;45(2):813-815. doi: 10.1007/s10072-023-07134-8. Epub 2023 Oct 17.

Authors

Marta Sequeira¹, Gonçalo Gama Lobo², Margarida Ferro³, Carlos Capela⁴

Affiliations

¹ Neurology Department, Hospital de São José, Centro Hospitalar Universitário Lisboa Central, 1150-199, Lisboa, Portugal. [email protected].
² Neurorradiology Department, Centro Hospitalar Universitário Lisboa Central, Lisboa, Portugal.
³ Neurology Department, Centro Hospitalar Universitário Lisboa Central, Lisboa, Portugal.
⁴ Multiple Sclerosis Centre of Integrated Responsibility, Centro Hospitalar Universitário Lisboa Central, Lisboa, Portugal.

PMID: 37848778
DOI: 10.1007/s10072-023-07134-8

No abstract available

Publication types

Letter

MeSH terms

Antibodies
Encephalomyelitis*
Glutamate Decarboxylase
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Multiple Sclerosis, Relapsing-Remitting*

Substances

Glutamate Decarboxylase
Antibodies